Tonix Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TNXP and other ETFs, options, and stocks.About TNXP
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800.
CEOSeth Lederman
CEOSeth Lederman
Employees81
Employees81
HeadquartersChatham, New Jersey
HeadquartersChatham, New Jersey
Founded2007
Founded2007
Employees81
Employees81
TNXP Key Statistics
Market cap171.02M
Market cap171.02M
Price-Earnings ratio-0.02
Price-Earnings ratio-0.02
Dividend yield—
Dividend yield—
Average volume795.78K
Average volume795.78K
High today$19.78
High today$19.78
Low today$18.76
Low today$18.76
Open price$18.76
Open price$18.76
Volume459.56K
Volume459.56K
52 Week high$130.00
52 Week high$130.00
52 Week low$6.76
52 Week low$6.76
TNXP News
TipRanks 2d
Tonix Pharma Begins FOCUS Study on AVP-D TreatmentElevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
TipRanks 2d
Tonix Pharmaceuticals announces first patient dosed in FOCUS study at MGHTonix Pharmaceuticals (TNXP) announced that the first patient has been dosed in the investigator-initiated FOCUS study at Massachusetts General Hospital, MGH, i...
People also own
Based on the portfolios of people who own TNXP. This list is generated using Robinhood data, and it’s not a recommendation.